Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| ShockWave Medical Inc | 1 | 0 | 0 | 0 | €306.90 | - | - |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.10 | €10.00 | 23.457% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €287.90 | €297.31 | 3.269% |
| Merit Medical Systems | 17 | 0 | 5 | 0 | €72.50 | €86.90 | 19.858% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €128.50 | €144.44 | 12.408% |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.50 | €3.25 | 117.275% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €93.00 | €124.85 | 34.245% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €306.90 | €335.03 | 9.165% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €70.56 | €80.00 | 13.379% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.53 | €4.63 | 30.968% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €75.50 | €75.94 | 0.577% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €72.50 | €79.00 | 8.966% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.20 | - | - |
| Lightpath Techs A | 4 | 0 | 1 | 0 | €1.29 | €2.78 | 115.860% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.02 | €3.75 | 85.736% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €26.40 | €28.29 | 7.162% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €139.65 | €236.30 | 69.207% |